Paracetamol and other non-opioid analgesics

Quick revision

Paracetamol relieves pain and fever through a mechanism that is still not fully established, and it is safe at licensed doses but hepatotoxic above them because a toxic metabolite overwhelms the liver's capacity to neutralise it.

• Mechanism: proposed to act through selective inhibition of cyclo-oxygenase within the central nervous system and effects on the hypothalamus, but the exact mechanism is not fully established. (1)
• Maximum recommended adult daily intake sits around 3 to 4 grams across a day, depending on the product and reference used; OTC labelling states severe liver damage can occur above 4,000 mg of acetaminophen in 24 hours. Exact dosing intervals belong in a prescribing reference and product labelling, not restated here. (1) (3)
• At therapeutic doses only a small fraction is metabolised via CYP2E1 to the toxic intermediate NAPQI, which is normally neutralised by conjugation with hepatic glutathione. (2)
• In overdose, NAPQI production outpaces glutathione supply; the excess NAPQI binds hepatic macromolecules and causes centrilobular (zone 3) hepatic necrosis. (2)
• Acetaminophen toxicity is the most common cause of acute liver failure in the United States and the second most common reason for liver transplantation worldwide. (2)
• N-acetylcysteine is the antidote and is most effective within 8 hours of an acute overdose, working by preventing NAPQI from binding hepatic macromolecules. (2)
• About half of acetaminophen poisonings are unintentional, often from taking more than one acetaminophen-containing product at once without realising it. (2)
• Chronic alcohol use, malnutrition and fasting raise hepatotoxicity risk at lower total doses than would otherwise cause harm, by upregulating CYP2E1 or depleting glutathione reserves. (2)

Overview

Paracetamol, known as acetaminophen in the United States, is the most widely used analgesic and antipyretic medicine in the world. It is available without a prescription, is a core ingredient in countless combination cold, flu and pain products, and is generally regarded as one of the safest analgesics available when used within its licensed dose — a safety record that makes its narrow margin above that dose easy to underestimate. (1)

Unlike NSAIDs, paracetamol's mechanism of action is not fully established. The best-supported explanation involves selective inhibition of cyclo-oxygenase within the central nervous system together with an effect on the hypothalamus, producing analgesia and reduced fever without the significant peripheral anti-inflammatory or antiplatelet action that defines the NSAID class. (1)

The defining safety issue is dose-dependent hepatotoxicity. A small fraction of a therapeutic dose is converted by CYP2E1 into the reactive metabolite NAPQI, which the liver's glutathione stores neutralise harmlessly. In overdose, glutathione is overwhelmed, NAPQI accumulates and binds hepatic macromolecules, and the result is centrilobular hepatic necrosis. Acetaminophen toxicity is the most common cause of acute liver failure in the United States and the second most common reason for liver transplantation worldwide — and roughly half of these poisonings are unintentional, commonly from combining more than one acetaminophen-containing product. (2)

Classification and drug examples

Best learned by exposure pattern, since the toxicity risk that defines this class is driven as much by how the drug is combined and taken as by the drug itself.

Mechanism of action

Paracetamol's analgesic and antipyretic mechanism is not fully established; the leading proposal is selective inhibition of cyclo-oxygenase within the central nervous system alongside an effect on the hypothalamus. Its toxicity mechanism, by contrast, is well characterised: a minor toxic metabolite, NAPQI, is safely neutralised at normal doses but overwhelms hepatic defences in overdose.

Molecular target

Proposed central cyclo-oxygenase inhibition and hypothalamic modulation (analgesic/antipyretic effect); CYP2E1-generated NAPQI (toxicity pathway)

Pharmacodynamic effect

Not applicable — this class is an analgesic/antipyretic, not an antimicrobial.

Effect kinetics

Not applicable in the antimicrobial sense; toxicity is dose-dependent rather than concentration- or time-dependent killing of an organism.

1. Central cyclo-oxygenase and hypothalamic effects (proposed analgesic/antipyretic mechanism)

   Paracetamol is proposed to selectively inhibit cyclo-oxygenase within the central nervous system and to directly affect the hypothalamus, reducing fever and pain perception without the significant peripheral prostaglandin inhibition that defines NSAIDs. (1)

2. Most of the dose follows safe conjugation pathways

   At therapeutic doses, most paracetamol is metabolised through glucuronidation and sulfation to inactive, nontoxic metabolites that are renally excreted. (2)

3. A small fraction generates NAPQI via CYP2E1

   Roughly 8% of a therapeutic dose is oxidised by CYP2E1 into the reactive toxic intermediate N-acetyl-p-benzoquinoneimine (NAPQI). (2)

4. Glutathione conjugates NAPQI harmlessly at normal doses

   Under normal conditions, NAPQI swiftly conjugates with hepatic glutathione to form nontoxic cysteine and mercaptate compounds, which is why therapeutic dosing does not injure the liver. (2)

5. Overdose overwhelms glutathione and causes hepatic necrosis

   In overdose, NAPQI production increases and depletes hepatic glutathione stores; the excess NAPQI binds covalently to hepatic macromolecules, particularly mitochondrial proteins, producing centrilobular (zone 3) hepatocellular necrosis. (2)

Major clinical uses

Pharmacokinetics

• This page gives no dose regimens by design. The maximum daily acetaminophen dose, individual dosing interval and paediatric weight-based dosing must come from a current prescribing reference and the treating clinician or pharmacist.
• Total daily acetaminophen exposure must be counted across every product a patient is taking, not just the one being newly prescribed, because combination products are the most common real-world route to accidental overdose. (2) (3)

Adverse effects

Common

• Generally well tolerated at licensed doses: At therapeutic doses, paracetamol lacks the GI, renal and antiplatelet effects that limit NSAID use, which is part of why it is favoured as a first-line agent. (1)

Serious adverse effects

• Hepatotoxicity and acute liver failure: Acetaminophen toxicity is the most common cause of acute liver failure in the United States and the second most common reason for liver transplantation worldwide; it results from NAPQI overwhelming hepatic glutathione in overdose. Emergency evaluation and N-acetylcysteine, most effective within 8 hours of an acute ingestion. (2)
• Severe liver damage from combination-product overdose: Taking a paracetamol-containing product together with another acetaminophen-containing product, or exceeding the maximum daily dose (labelled as above 4,000 mg/24h on US OTC packaging), can cause severe liver damage. Checking every medicine label for acetaminophen content before adding a new product is the standard way to avoid unintentional double-dosing. (3)

Drug-specific effects

• Paracetamol (acetaminophen) in chronic alcohol users: Hepatotoxicity risk at lower total doses because CYP2E1 upregulation increases NAPQI generation from a given dose. (2)
• Paracetamol (acetaminophen) with malnutrition or fasting: Reduced glucuronidation and lower glutathione reserves raise hepatotoxicity risk at doses that would otherwise be tolerated. (2)

Contraindications, precautions and interactions

Contraindications

• Known hypersensitivity to acetaminophen. (1)
• Severe active hepatic impairment or acute liver failure, without specialist direction. (2)

Precautions

• Chronic alcohol use, malnutrition, or fasting states, which lower the hepatotoxicity threshold. (2)
• Concurrent use of any other acetaminophen-containing product, prescription or nonprescription. (3)
• Pre-existing hepatic disease. (2)

Drug interactions

• CYP2E1-inducing medications and chronic alcohol use: Increase NAPQI generation from a given acetaminophen dose, raising hepatotoxicity risk. (2)
• Other acetaminophen-containing products (cold/flu remedies, combination analgesics): Additive total acetaminophen exposure that can unintentionally exceed the maximum daily dose. (3)

Comparison tables

High-yield exam pearls

• Paracetamol is the analgesic whose exact mechanism is still debated. (1) Unlike NSAIDs, whose COX mechanism is well characterised, paracetamol's mechanism is only proposed — central COX inhibition and hypothalamic effects — and remains incompletely established despite the drug's universal use.
• One metabolite explains the whole toxicity story. (2) NAPQI is produced in tiny amounts at normal doses and safely neutralised by glutathione. Overdose does not introduce a new toxic pathway — it simply produces more NAPQI than glutathione can conjugate, and the excess destroys hepatocytes.
• The most dangerous overdoses are often accidental. (2) About half of acetaminophen poisonings are unintentional, typically from a patient taking more than one acetaminophen-containing product — for example a cold remedy plus a separate pain reliever — without realising both contain the same drug.
• The antidote has a clock attached. (2) N-acetylcysteine is most effective within 8 hours of an acute overdose. This time-dependence is why acetaminophen overdose is treated as time-critical even when the patient looks well initially.
• Chronic drinkers and malnourished patients need a lower threshold of suspicion. (2) Chronic alcohol use upregulates CYP2E1, generating more NAPQI from the same dose, while malnutrition and fasting reduce glucuronidation and glutathione reserves — both lower the dose at which hepatotoxicity becomes possible.

Common exam traps

• Trap: "Paracetamol works the same way as NSAIDs, just weaker." Actually: Paracetamol's mechanism is not the same well-established peripheral COX inhibition seen with NSAIDs. It is proposed to act more centrally, and the exact mechanism remains incompletely established — a genuinely different, less certain pharmacology, not simply a weaker NSAID. (1)
• Trap: "Acetaminophen overdose only matters if it was taken intentionally in one large dose." Actually: About half of poisonings are unintentional, frequently from combining multiple acetaminophen-containing products, and chronic low-margin dosing in a patient with alcohol use or malnutrition can also cause hepatotoxicity without any single large overdose. (2)
• Trap: "If the patient feels fine hours after an overdose, no treatment is needed." Actually: Acetaminophen hepatotoxicity is often clinically silent early on; N-acetylcysteine is most effective within 8 hours of ingestion, so treatment decisions are based on ingested dose and timing, not on how the patient currently feels. (2)

Self-test questions

Answers are hidden until you open them. These questions are written from this page's cited content and are for study only — they are not clinical guidance.

1. What is the current understanding of paracetamol's mechanism of action?

   • It is a well-characterised peripheral COX-1 inhibitor identical in mechanism to ibuprofen
   • It is proposed to act through selective central cyclo-oxygenase inhibition and hypothalamic effects, but the exact mechanism is not fully established
   • It works exclusively through mu-opioid receptor agonism
   • It blocks voltage-gated sodium channels in peripheral nerves
   Show answer

   Answer: It is proposed to act through selective central cyclo-oxygenase inhibition and hypothalamic effects, but the exact mechanism is not fully established

   Paracetamol's mechanism is incompletely established. The best-supported proposal involves selective inhibition of cyclo-oxygenase within the central nervous system and an effect on the hypothalamus, which is a materially different and less certain picture than the well-defined peripheral COX mechanism of NSAIDs. (1)

2. At therapeutic doses, how does the body handle the toxic metabolite NAPQI?

   • NAPQI is not produced at therapeutic doses at all
   • A small amount of NAPQI is produced via CYP2E1 and swiftly conjugated with hepatic glutathione into nontoxic compounds
   • NAPQI is excreted unchanged by the kidney before it can cause harm
   • NAPQI is converted back into paracetamol by the liver
   Show answer

   Answer: A small amount of NAPQI is produced via CYP2E1 and swiftly conjugated with hepatic glutathione into nontoxic compounds

   At therapeutic doses, only a small fraction of paracetamol is metabolised via CYP2E1 into NAPQI, which is rapidly conjugated with hepatic glutathione to form nontoxic cysteine and mercaptate compounds — this is the normal, safe pathway. (2)

3. What actually causes liver injury in paracetamol overdose?

   • Paracetamol itself directly destroys hepatocytes
   • Increased NAPQI production depletes glutathione stores, and the excess NAPQI binds hepatic macromolecules, causing centrilobular necrosis
   • Paracetamol overdose causes an allergic hypersensitivity reaction in the liver
   • The kidney fails first, and liver injury is a secondary consequence
   Show answer

   Answer: Increased NAPQI production depletes glutathione stores, and the excess NAPQI binds hepatic macromolecules, causing centrilobular necrosis

   In overdose, increased NAPQI production outpaces the liver's glutathione supply. The unconjugated NAPQI binds covalently to hepatic macromolecules, particularly mitochondrial proteins, producing centrilobular (zone 3) hepatocellular necrosis. (2)

4. Why is N-acetylcysteine most effective when given within 8 hours of an acute paracetamol overdose?

   • It has no time-dependence and works equally well at any interval
   • It works by replenishing/mimicking glutathione to prevent NAPQI from binding hepatic macromolecules, before that binding and the resulting necrosis have already occurred
   • It only works if given before the drug is absorbed
   • It directly reverses hepatic necrosis that has already occurred
   Show answer

   Answer: It works by replenishing/mimicking glutathione to prevent NAPQI from binding hepatic macromolecules, before that binding and the resulting necrosis have already occurred

   N-acetylcysteine acts by preventing NAPQI from binding to hepatic macromolecules. Once that binding has already happened and hepatocyte injury is underway, the drug's benefit diminishes, which is why early administration, ideally within 8 hours, matters so much. (2)

5. Why are chronic alcohol users at higher hepatotoxicity risk from the same paracetamol dose as other patients?

   • Alcohol has no effect on paracetamol metabolism
   • Chronic alcohol use upregulates CYP2E1, increasing NAPQI production from a given dose, and can also affect glutathione reserves
   • Alcohol blocks paracetamol absorption entirely, so more must be taken to reach the same effect
   • Chronic alcohol users metabolise paracetamol entirely through a nontoxic pathway
   Show answer

   Answer: Chronic alcohol use upregulates CYP2E1, increasing NAPQI production from a given dose, and can also affect glutathione reserves

   Chronic alcohol ingestion is a documented risk factor because it upregulates CYP2E1, the enzyme that produces NAPQI, meaning more toxic metabolite is generated from the same paracetamol dose than in a person without that enzyme induction. (2)

6. Why does the FDA-approved consumer label warn against taking a paracetamol-containing product together with another acetaminophen-containing product?

   • Because the two drugs interact pharmacodynamically to increase pain
   • Because doing so risks unknowingly exceeding the maximum daily acetaminophen dose and causing severe liver damage
   • Because it voids the product warranty
   • Because acetaminophen from two products cancels out and neither works
   Show answer

   Answer: Because doing so risks unknowingly exceeding the maximum daily acetaminophen dose and causing severe liver damage

   Multiple over-the-counter and prescription products contain acetaminophen (for example combination cold remedies and combination analgesics). Taking more than one at a time is a common, real route to accidental overdose and severe liver damage, which is exactly what the label warning is designed to prevent. (3)

Frequently asked questions

References

1. Acetaminophen (StatPearls) StatPearls Publishing / NCBI Bookshelf, 2025
2. Acetaminophen Toxicity (StatPearls) StatPearls Publishing / NCBI Bookshelf, 2025
3. Tylenol Extra Strength (acetaminophen) — FDA-approved consumer label (DailyMed) DailyMed, U.S. National Library of Medicine, 2026

Related drug classes

• NSAIDs, including COX-2 selective agents
• Opioid analgesics
• Gabapentinoids and neuropathic pain agents

Back to the Analgesia and anaesthesia classification · Pharmacology Study Corner